Obesity: New life for antidiabetic drugs.
Houtkooper
Riekelt H
RH
Auwerx
Johan
J
D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D051360:Cyclin-Dependent Kinase 5 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D004041:Dietary Fats / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000378:metabolism; D008024:Ligands; D051379:Mice; D009765:Obesity / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology; D047495:PPAR gamma / Q000819:agonists / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use
D004041:Dietary Fats; D007328:Insulin; D008024:Ligands; D047495:PPAR gamma; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D051360:Cyclin-Dependent Kinase 5